Rs3825942

From SNPedia

Jump to: navigation, search
is asnp
is mentioned by
dbSNPrs3825942
hapmaprs3825942
hgdprs3825942
ensemblrs3825942
gopubmedrs3825942
scholarrs3825942
googlers3825942
pharmgkbrs3825942
hgvbaseg2prs3825942
medrefsnprs3825942
23andMers3825942
SNP Nexus

GeneLOXL1
Chromosome15
Orientationminus
Position72006634
GenotypeEffect
rs3825942(C;C)10x higher glaucoma risk
rs3825942(C;T)possibly higher glaucoma risk?
rs3825942(T;T)average


Genotypes Magnitude Summary
Rs3825942(C;C) 3.53.5 10x higher glaucoma risk
Rs3825942(C;T) 11 possibly higher glaucoma risk?
Rs3825942(T;T) 00 average
rs3825942, also known as G153D, a SNP causing an amino acid change in the lysyl oxidase 1 LOXL1 gene, has been linked to exfoliation glaucoma (also known as exfoliation syndrome). This form of glaucoma causes up to 10% of the cases of blindness in many countries, including the US. [PMID 17690259] From the abstract of this study: "Approximately 25% of the general population is homozygous for the highest risk haplotype and their risk of suffering XFG (exfoliation glaucoma) is over 100 times that of those only carrying low-risk haplotypes."

The risk allele for this SNP is rs3825942(C), as oriented with respect to the dbSNP entry, and it confers a estimated relative risk (by itself) of 27 compared to the (T) allele. The odds ratio is 20.10 (CI 10.80-37.41). [Note that the (C) allele is actually quite common in most European populations.]

A meta-analysis including 24 articles across 5 ethnicities (Caucasian, African, Japanese, Indian, and Chinese) concluded that rs3825942 is the common disease-associated SNP in all populations, whereas rs1048661 and rs2165241 were inconsistent. The odds ratio is approximately 10 for rs3825942(C;C), while the heterozygote rs3825942(C;T) was not statistically significant. rs3825942 was not associated with primary open angle glaucoma (POAG).[PMID 20142848]

With so many people at high risk, shouldn't the number of cases be much higher? Not necessarily, since glaucoma risk only becomes high in older individuals. [To put it another way: plenty of folks don't live long enough to find out if they would have gotten glaucoma.] The estimate for glaucoma incidence worldwide is 10-20% only for individuals over 60 years of age; in Iceland, where glaucoma incidence is high, 40% of individuals 80 or older show signs of exfoliation syndrome, which has been seen to convert to exfolation glaucoma at a rate of 60% - over a 15 year period. [PMID 12928689, PMID 10463402, PMID 17224761]

discussed in this blog post

[PMID 18385788] rs1048661 (G), rs3825942 (G), and rs2165241 (T) are highly associated with XFS and XFG in American and European populations. The GGT haplotype constitutes a major risk haplotype for exfoliation.

[PMID 18385063] Confirmed as risk for pseudoexfoliation (PEX) and pseudoexfoliation glaucoma (PEXG) in populations of German and Italian descent.

Neighborrs1048661
Distance36
? (C;C) (C;T) (T;T)
GWAS
SNP rs3825942
PubMedID [PMID 17690259]
Condition Exfoliation glaucoma
Gene LOXL1
Risk Allele G
pValue 3.00E-021
OR 20.1
95% CI 10.80-37.41


[PMID 19503743] Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese

Related to LYSYL OXIDASE-LIKE 1; LOXL1 according to omim 153456. See also


[PMID 19936304] Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population

PharmGKBPA162355582
Name
AnnotationIn a case-control GWAS of Icelandic and Swedish patients, the G allele of rs3825942 was significantly associated with risk of Exfoliation Syndrome Glaucoma.
GeneLOXL1
Featue
EvidencePubMed ID:17690259
Drugs
DiseasesExfoliation Syndrome
Curation LevelCurated